Taiwan’s fast-track approval process accelerates access to drugs addressing urgent medical needs, such as orphan drugs or treatments for serious conditions. The TFDA offers expedited pathways, including priority review, accelerated approval, and abbreviated review, reducing evaluation timelines. These programs ensure timely patient access while maintaining rigorous safety and efficacy standards